...
twst-img

Twist Bioscience Corp, Common Stock

TWST

NSQ

$43.13

-$1.54

(-3.45%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.51B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.81M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
1.15M
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.63
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.81 L
$44.9 H
$43.13

About Twist Bioscience Corp, Common Stock

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTWSTSectorS&P500
1-Week Return38.1%1.6%2.88%
1-Month Return30.82%-0.13%-0.41%
3-Month Return23.33%-0.89%4.04%
6-Month Return136.46%11.98%19.15%
1-Year Return221.87%8.71%27.1%
3-Year Return-63.05%20.41%28.11%
5-Year Return98.39%74.87%94.84%
10-Year Return208.07%189.94%231.14%

Financials

Sep '19Sep '20Sep '21Sep '22Sep '235YR TREND
Total Revenue54.38M90.10M132.33M203.56M245.11M[{"date":"2019-09-30","value":22.19,"profit":true},{"date":"2020-09-30","value":36.76,"profit":true},{"date":"2021-09-30","value":53.99,"profit":true},{"date":"2022-09-30","value":83.05,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Cost of Revenue47.43M61.41M80.62M119.33M155.38M[{"date":"2019-09-30","value":30.52,"profit":true},{"date":"2020-09-30","value":39.52,"profit":true},{"date":"2021-09-30","value":51.89,"profit":true},{"date":"2022-09-30","value":76.8,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Gross Profit6.96M28.69M51.71M84.23M89.73M[{"date":"2019-09-30","value":7.76,"profit":true},{"date":"2020-09-30","value":31.98,"profit":true},{"date":"2021-09-30","value":57.63,"profit":true},{"date":"2022-09-30","value":93.88,"profit":true},{"date":"2023-09-30","value":100,"profit":true}]
Gross Margin12.80%31.85%39.08%41.38%36.61%[{"date":"2019-09-30","value":30.92,"profit":true},{"date":"2020-09-30","value":76.96,"profit":true},{"date":"2021-09-30","value":94.44,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":88.47,"profit":true}]
Operating Expenses115.81M146.27M204.97M333.26M296.63M[{"date":"2019-09-30","value":34.75,"profit":true},{"date":"2020-09-30","value":43.89,"profit":true},{"date":"2021-09-30","value":61.51,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":89.01,"profit":true}]
Operating Income(108.85M)(117.58M)(153.26M)(249.02M)(217.16M)[{"date":"2019-09-30","value":-10885000000,"profit":false},{"date":"2020-09-30","value":-11757900000,"profit":false},{"date":"2021-09-30","value":-15326000000,"profit":false},{"date":"2022-09-30","value":-24902100000,"profit":false},{"date":"2023-09-30","value":-21715900000,"profit":false}]
Total Non-Operating Income/Expense3.21M(21.26M)(700.00K)23.73M3.44M[{"date":"2019-09-30","value":13.53,"profit":true},{"date":"2020-09-30","value":-89.59,"profit":false},{"date":"2021-09-30","value":-2.95,"profit":false},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":14.48,"profit":true}]
Pre-Tax Income(107.38M)(139.55M)(154.03M)(228.27M)(203.47M)[{"date":"2019-09-30","value":-10737700000,"profit":false},{"date":"2020-09-30","value":-13954900000,"profit":false},{"date":"2021-09-30","value":-15402800000,"profit":false},{"date":"2022-09-30","value":-22827400000,"profit":false},{"date":"2023-09-30","value":-20346600000,"profit":false}]
Income Taxes292.00K382.00K(1.93M)(10.41M)1.15M[{"date":"2019-09-30","value":25.35,"profit":true},{"date":"2020-09-30","value":33.16,"profit":true},{"date":"2021-09-30","value":-167.53,"profit":false},{"date":"2022-09-30","value":-903.73,"profit":false},{"date":"2023-09-30","value":100,"profit":true}]
Income After Taxes(107.67M)(139.93M)(152.10M)(217.86M)(204.62M)[{"date":"2019-09-30","value":-10766900000,"profit":false},{"date":"2020-09-30","value":-13993100000,"profit":false},{"date":"2021-09-30","value":-15209800000,"profit":false},{"date":"2022-09-30","value":-21786300000,"profit":false},{"date":"2023-09-30","value":-20461800000,"profit":false}]
Income From Continuous Operations(107.67M)(139.93M)(152.10M)(217.86M)(204.62M)[{"date":"2019-09-30","value":-10766900000,"profit":false},{"date":"2020-09-30","value":-13993100000,"profit":false},{"date":"2021-09-30","value":-15209800000,"profit":false},{"date":"2022-09-30","value":-21786300000,"profit":false},{"date":"2023-09-30","value":-20461800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-09-30","value":"-","profit":true},{"date":"2020-09-30","value":"-","profit":true},{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true}]
Net Income(107.67M)(139.93M)(152.10M)(217.86M)(204.62M)[{"date":"2019-09-30","value":-10766900000,"profit":false},{"date":"2020-09-30","value":-13993100000,"profit":false},{"date":"2021-09-30","value":-15209800000,"profit":false},{"date":"2022-09-30","value":-21786300000,"profit":false},{"date":"2023-09-30","value":-20461800000,"profit":false}]
EPS (Diluted)(3.99)(3.06)(3.12)(4.03)(3.37)[{"date":"2019-09-30","value":-399,"profit":false},{"date":"2020-09-30","value":-306,"profit":false},{"date":"2021-09-30","value":-312,"profit":false},{"date":"2022-09-30","value":-403,"profit":false},{"date":"2023-09-30","value":-337,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TWST
Current Ratio 5.51
Quick Ratio 5.06

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TWST
ROA (LTM) -15.63%
ROE (LTM) -30.40%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TWST
Debt Ratio Lower is generally better. Negative is bad. 0.20
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.80
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 1.25

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TWST
Trailing PE NM
Forward PE NM
P/S (TTM) 6.76
P/B 3.01
Price/FCF NM
EV/R 5.93
EV/Ebitda NM
PEG NM

News

TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024

Twist Bioscience (NASDAQ: TWST ) just reported results for the second quarter of 2024. Twist Bioscience reported earnings per share of -79 cents. This was above the analyst estimate for EPS of -81 cents. The company reported revenue of $75.30 million. This was 6.58% better than the analyst estimate for revenue of $70.65 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I.

3 May, 2024 a 1:00 am InvestorPlace

Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results

– Record revenue of $75.3M in 2QFY24, an increase of 25% over $60.2M in 2QFY23 – – Orders increased to $93.2M in 2QFY24, growth of 45% over $64.2M in 2QFY23 – — Increased FY 2024 revenue guidance to a range of $300M to $304M ; Increased FY 2024 gross margin guidance to a range of 41.5 to 42.0% — —

2 May, 2024 a 8:05 pm Investors Twist Bioscience

Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results | TWST Stock News

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal 2024 ended March 31, 2024.. "This was another very strong quarter for Twist with both revenue and orders increasing…

2 May, 2024 a 8:05 pm Stock Titan

FAQs

What is Twist Bioscience Corp share price today?

Twist Bioscience Corp (TWST) share price today is $43.13

Can Indians buy Twist Bioscience Corp shares?

Yes, Indians can buy shares of Twist Bioscience Corp (TWST) on Vested. To buy Twist Bioscience Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TWST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Twist Bioscience Corp be purchased?

Yes, you can purchase fractional shares of Twist Bioscience Corp (TWST) via the Vested app. You can start investing in Twist Bioscience Corp (TWST) with a minimum investment of $1.

How to invest in Twist Bioscience Corp shares from India?

You can invest in shares of Twist Bioscience Corp (TWST) via Vested in three simple steps:

  • Click on Sign Up or Invest in TWST stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Twist Bioscience Corp shares
What is Twist Bioscience Corp 52-week high and low stock price?

The 52-week high price of Twist Bioscience Corp (TWST) is $44.9. The 52-week low price of Twist Bioscience Corp (TWST) is $11.81.

What is Twist Bioscience Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Twist Bioscience Corp (TWST) is NM

What is Twist Bioscience Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Twist Bioscience Corp (TWST) is 3.01

What is Twist Bioscience Corp dividend yield?

The dividend yield of Twist Bioscience Corp (TWST) is 0.00%

What is the Market Cap of Twist Bioscience Corp?

The market capitalization of Twist Bioscience Corp (TWST) is $2.51B

What is Twist Bioscience Corp’s stock symbol?

The stock symbol (or ticker) of Twist Bioscience Corp is TWST

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top